Evidence map›Paper›PMID 42018843›Full record

ArticleRevista da Associacao Medica Brasileira (1992)2026

Artificial intelligence chatbots and idiopathic pulmonary fibrosis: are they ready to inform patients?

Merve Yumrukuz Şenel, Emine Ayan, Mustafa Çolak, Hikmet Çoban, Fuat Erel, Nurhan Sarıoğlu

Abstract read
In one paragraph

Article in Revista da Associacao Medica Brasileira (1992), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Merve Yumrukuz ŞenelBalıkesir University, Faculty of Medicine, Department of Chest Diseases - Balıkesir, Türkiye.ORCID http://orcid.org/0000-0003-0205-5075
Emine AyanBalıkesir University, Faculty of Medicine, Department of Chest Diseases - Balıkesir, Türkiye.ORCID http://orcid.org/0009-0002-1037-5167
Mustafa ÇolakBalıkesir University, Faculty of Medicine, Department of Chest Diseases - Balıkesir, Türkiye.ORCID http://orcid.org/0000-0002-8458-3535
Hikmet ÇobanBalıkesir University, Faculty of Medicine, Department of Chest Diseases - Balıkesir, Türkiye.ORCID http://orcid.org/0000-0001-6730-9932
Fuat ErelBalıkesir University, Faculty of Medicine, Department of Chest Diseases - Balıkesir, Türkiye.ORCID http://orcid.org/0000-0002-4788-8161
Nurhan SarıoğluBalıkesir University, Faculty of Medicine, Department of Chest Diseases - Balıkesir, Türkiye.ORCID http://orcid.org/0000-0002-5180-9649

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this study was to determine the quality, reliability, and readability of the responses provided by artificial intelligence chatbots about idiopathic pulmonary fibrosis.

methodsThe clinically relevant questions about idiopathic pulmonary fibrosis diagnosis, treatment, prognosis, and lifestyle management were submitted to four widely used artificial intelligence chatbots, including ChatGPT, Perplexity, Gemini, and Copilot. Responses were assessed by five clinicians based on readability, understandability, quality, and content reliability using standardized tools.

resultsThe overall readability of chatbot-generated responses was low, corresponding to high educational requirements. Understandability ranged from moderate to good, whereas actionability remained moderate. Gemini produced the most readable and understandable outputs. Journal of the American Medical Association and Likert scores indicated limited source transparency but good guideline concordance. DISCERN analysis for the treatment question showed significant variation (p=0.003), with Perplexity achieving the highest total score.

conclusionAlthough artificial intelligence chatbots offer rapid and accessible information, their readability and source reliability remain limited. These findings highlight the necessity of expert supervision and further model improvement before artificial intelligence chatbots can be safely integrated into patient education.

Indexed as

Artificial IntelligenceIdiopathic Pulmonary FibrosisPatient Education as TopicComprehensionHumansReproducibility of Results

Identifiers

PMID42018843
PMCPMC13102406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.